Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Kalorama: Retail Clinics a Source of Business for IVD, Pharma

By PR Newswire | September 28, 2016

With the number of U.S. clinics located within retail locations exceeding 2,000, they have become an important target for IVD products, according to Kalorama Information. There is over $200 billion in supplier sales to these centers, Kalorama found in its most recent research report, Retail Clinics 2016. And this is up from five years ago. 

Retail clinics are small healthcare venues entirely within a retail store, usually staffed by a nurse practitioner in states where the scope of practice permits. They tend to offer later and weekend hours for busy shoppers and provide routine services. Retail clinic locations have expanded from 1,605 to 2,215 in the United States between 2011 and 2016, with drug store chains CVS and Walgreens accounting for the largest share of the locations. 

According to the findings, this trend is now large enough to be part of manufacturer strategy and a realistic sales target for IVD and pharmaceutical companies. Kalorama said that sales of three types of products to retail clinics—vaccines, POC tests, and lab tests—reached $240 million in 2015, with vaccines accounting for a greater share than POC tests or laboratory tests. This reflects total annual growth of over 26 percent per year since 2010, when retail clinics accounted for about $75 million in purchases of these products.

“Point-of-care test makers in particular should be aware of this growing trend,” said Bruce Carlson, Publisher of Kalorama Information in a recent webinar. “You see companies like Alere and Roche making products for common ailments that can fit in smaller locales. They are thinking of urgent care, but also with an eye towards the new venues.”

Roche Diagnostics, for instance, has developed the cobas Liat for smaller venues. The company recently announced that its cobas Strep A, the first molecular PCR test to deliver laboratory quality results in ~15 minutes was “now available for use in physician offices and retail clinics.”

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news! 

Related Articles Read More >

These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
Thermo Fisher Scientific
Thermo Fisher to invest $2B on U.S. manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE